Risk of lymphoma associated with combination anti–tumor necrosis factor and immunomodulator therapy for the treatment of Crohn's disease: a meta-analysis
CA Siegel, SM Marden, SM Persing, RJ Larson… - Clinical …, 2009 - Elsevier
BACKGROUND & AIMS: Although anti–tumor necrosis factor (TNF) therapy can effectively
treat Crohn's disease (CD), there is concern that it might increase the risk of non-Hodgkin's …
treat Crohn's disease (CD), there is concern that it might increase the risk of non-Hodgkin's …
Risk of Lymphoma Associated With Combination Anti–Tumor Necrosis Factor and Immunomodulator Therapy for the Treatment of Crohn's Disease: A Meta-Analysis
CA Siegel, SM Marden, SM Persing… - Clinical …, 2009 - cghjournal.org
Background & Aims Although anti–tumor necrosis factor (TNF) therapy can effectively treat
Crohn's disease (CD), there is concern that it might increase the risk of non-Hodgkin's …
Crohn's disease (CD), there is concern that it might increase the risk of non-Hodgkin's …
[HTML][HTML] Risk of Lymphoma Associated With Combination Anti–Tumor Necrosis Factor and Immunomodulator Therapy for the Treatment of Crohn's Disease: A Meta …
CA Siegel, SM Marden, SM Persing… - … and hepatology: the …, 2009 - ncbi.nlm.nih.gov
Methods MEDLINE, EMBASE, Cochrane Collaboration, and Web of Science were searched.
Inclusion criteria included randomized controlled trials, cohort studies, or case series …
Inclusion criteria included randomized controlled trials, cohort studies, or case series …
[引用][C] Risk of Lymphoma Associated With Combination Anti–Tumor Necrosis Factor and Immunomodulator Therapy for the Treatment of Crohn's Disease: A Meta …
CA Siegel, SM Marden, SM Persing… - Clinical …, 2009 - cir.nii.ac.jp
Risk of Lymphoma Associated With Combination Anti–Tumor Necrosis Factor and
Immunomodulator Therapy for the Treatment of Crohn's Disease: A Meta-Analysis | CiNii …
Immunomodulator Therapy for the Treatment of Crohn's Disease: A Meta-Analysis | CiNii …
Risk of lymphoma associated with combination anti-tumor necrosis factor and immunomodulator therapy for the treatment of Crohn's disease: a meta-analysis
CA Siegel, SM Marden, SM Persing… - … : the official clinical …, 2009 - pubmed.ncbi.nlm.nih.gov
Background & aims Although anti-tumor necrosis factor (TNF) therapy can effectively treat
Crohn's disease (CD), there is concern that it might increase the risk of non-Hodgkin's …
Crohn's disease (CD), there is concern that it might increase the risk of non-Hodgkin's …
Risk of lymphoma associated with combination anti-tumor necrosis factor and immunomodulator therapy for the treatment of Crohn's disease: a meta-analysis.
CA Siegel, SM Marden, SM Persing… - … and Hepatology: the …, 2009 - europepmc.org
Methods MEDLINE, EMBASE, Cochrane Collaboration, and Web of Science were searched.
Inclusion criteria included randomized controlled trials, cohort studies, or case series …
Inclusion criteria included randomized controlled trials, cohort studies, or case series …
Risk of Lymphoma Associated With Combination Anti–Tumor Necrosis Factor and Immunomodulator Therapy for the Treatment of Crohn's Disease: A Meta-Analysis
CA Siegel, SM Marden, SM Persing, RJ Larson… - Clinical …, 2009 - infona.pl
Although anti–tumor necrosis factor (TNF) therapy can effectively treat Crohn's disease (CD),
there is concern that it might increase the risk of non-Hodgkin's lymphoma (NHL). A meta …
there is concern that it might increase the risk of non-Hodgkin's lymphoma (NHL). A meta …
Risk of lymphoma associated with combination anti-tumor necrosis factor and immunomodulator therapy for the treatment of Crohn's disease: a meta-analysis.
CA Siegel, SM Marden, SM Persing… - … and Hepatology: the …, 2009 - europepmc.org
Methods MEDLINE, EMBASE, Cochrane Collaboration, and Web of Science were searched.
Inclusion criteria included randomized controlled trials, cohort studies, or case series …
Inclusion criteria included randomized controlled trials, cohort studies, or case series …
[HTML][HTML] Risk of lymphoma associated with combination anti-tumor necrosis factor and immunomodulator therapy for the treatment of Crohn's disease: a meta-analysis
CA Siegel, SM Marden, SM Persing… - Database of Abstracts …, 2009 - ncbi.nlm.nih.gov
The authors concluded that anti-tumour necrosis factor agents combined with
immunomodulators was associated with an increased risk of non-Hodgkin's lymphoma in …
immunomodulators was associated with an increased risk of non-Hodgkin's lymphoma in …